Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up

Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up

Background: Lobectomy with preservation of the contralateral lobe has already become the most preferred surgical method for patients with low-risk thyroid cancer. The incidence of and risk factors for the development of hypothyroidism after lobectomy for thyroid cancer remains unclear. The previous...

Full description

Bibliographic Details
Main Authors: Soo Young Kim, Hee Jun Kim, Seok-Mo Kim, Hojin Chang, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Endocrinology
Subjects:
thyroid stimulating hormone suppression
hypothyroidism
low-risk differentiated thyroid cancer
levothyroxine supplementation
thyroid lobectomy
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00520/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2020.00520/full

Similar Items